Sarepta Therapeutics, Inc. (SRPT) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 8, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 8, 2026 filed Sept. 4, 2026 | Wong Ryan Ho-Yan Chief Financial Officer | $294,904 | 13,272 | −10% | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 4, 2026 | Estepan Ian Michael Chief Operating Officer | $551,034 | 24,799 | −12% | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 4, 2026 | Rothfuss Cristin EVP, General Counsel | $489,396 | 22,025 | −16% | No | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 4, 2026 | Rodino-Klapac Louise President, R&D and Tech Ops | $476,019 | 21,423 | −10% | No | |
|
|
||||||
| July 29, 2026 filed July 28, 2026 | SEVERINO MICHAEL Chief Executive Officer | $0 | 2,980,446 | +51% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free